Biocon Acquires All Equity of Biocon Biologics Limited, Increases Share Capital via Preferential Allotment

Biocon Acquires All Equity of Biocon Biologics Limited, Increases Share Capital via Preferential Allotment

Biocon Acquires All Equity of Biocon Biologics Limited, Increases Share Capital via Preferential Allotment​

Biocon Limited has completed the acquisition of all equity shares in its material subsidiary, Biocon Biologics Limited (BBL). The company subsequently allotted a tranche of its own equity shares to the selling shareholders as consideration for the acquisition.

The acquisition process was finalized on June 29, 2026, making BBL a wholly-owned subsidiary of Biocon Limited effective that day. During this transaction, the Company acquired 11,536,956 equity shares of BBL from 127 selling shareholders.

As part of the consideration for the acquisition, Biocon issued and allotted 8,786,362 fully paid-up equity shares to the aforementioned Allottees on a preferential basis. The allotment was conducted at an issue price of Rs. 376.41 per equity share. The company confirmed that all allotted equity shares will rank pari-passu with its existing equity shares.

The transaction resulted in a notable increase in the Company's issued, subscribed, and paid-up equity share capital.

Financial Structure Update​

The acquisition and subsequent preferential allotment led to the following changes in Biocon Limited's capital structure:

Capital ComponentBefore TransactionAfter Transaction
Issued & Paid-up CapitalRs. 8,10,45,38,865/-Rs. 8,14,84,70,675/-
Total Equity Shares Outstanding1,62,09,07,7731,62,96,94,135

The Preferential Issue & Allotment Committee of the company oversaw this transaction in accordance with the terms established in the share purchase agreements entered into with the Allottees. The total number of equity shares allotted during this process was 87,86,362, distributed among the 127 identified sellers.

The list detailing the names of the Allottees and the corresponding number of BBL equity shares acquired alongside the number of Biocon equity shares allocated is available for reference.

BIOCON Stock Price Movement​

Shares of Biocon Limited on Monday slipped by 0.32%, settling at ₹415.25 after a day of trading. The stock traded a volume of 3.28 million shares, hovering near its intraday low of ₹413.5.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top